Navigation Links
The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement
Date:7/22/2014

Piscataway, NJ (PR Web) July 21, 2014 (PRWEB) July 23, 2014

The New Jersey Center for Biomaterials, at Rutgers University.

The goal of the Symposium is to exchange information and ideas across the full spectrum of scientists working in the biomaterials field, by focusing on selected research and development topics that represent the most promising directions for ultimate medical application. Activities have been programmed to:

  •     Provide faculty and government scientists with opportunities for high-level scientific interactions with leading investigators in similar and complementary disciplines; and with commercially oriented biomaterials users
  •     Provide students and postdoctoral associates with opportunities both to learn about the most advanced biomaterials-related research, and to present their own research in a professional forum; and to interact with industrial scientists in furtherance of exploring future career options
  •     Provide industrial scientists with access to leading-edge academic biomaterials researchers, and the opportunity to contribute to defining university-based research directions
  •     Provide clinicians with current information on biomaterials research and product development, and the opportunity to shape R&D programs through clinical input

Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

The Society For Biomaterials is a multidisciplinary society of academic, healthcare, governmental and business professionals in the US, dedicated to promoting advances in all aspects of biomaterial science, education and professional standards.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001
symposium(at)dls(dot)rutgers(dot)edu

Read the full story at http://www.prweb.com/releases/2014/07/prweb12033279.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
2. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
3. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
4. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
5. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
6. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
7. Amarantus BioSciences Featured in BioWorld Today, Brewer Sports Symposium and Opportunist Magazine
8. Tanke BioSciences To Host Leading Symposium On Food Safety, June 24-25
9. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
10. Van Andel Institute Research Symposium Showcases Latest Developments In Parkinsons Research
11. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016  Bayer today announced that ... Stivarga ® (regorafenib) tablets for the treatment ... met its primary endpoint of a statistically significant ... evaluated the efficacy and safety of regorafenib in ... treatment with sorafenib. The safety and tolerability were ...
(Date:5/4/2016)... May 4, 2016 According to ... "Metabolomics Market - Global Industry Analysis, Size, Share, Growth, ... is anticipated to expand at a CAGR of 17.1% ... by 2024. Metabolomics is the extensive study ... biofluids, tissues or organisms. Together, these small molecules and ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nutrafol®, a ... help treat hormonal and stress related hair loss. With patent-pending formulas for both ... key opinion leaders in the medical and salon channels nationwide. , Dermatologists, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Morf ... and compliance training platform on mobile devices, today released a new interactive ... for Medical Devices. The course is essential for owners or operators of places ...
Breaking Biology Technology:
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):